DA
Therapeutic Areas
Novatek Pharmaceuticals Pipeline
| Drug | Indication | Phase |
|---|---|---|
| NP-101 (TQ Formula) | COVID-19 (Outpatient) | Phase 2 |
| NP-101 | Oncology (Various Cancers) | Phase 1/2 |
| Drug | Indication | Phase |
|---|---|---|
| NP-101 (TQ Formula) | COVID-19 (Outpatient) | Phase 2 |
| NP-101 | Oncology (Various Cancers) | Phase 1/2 |